These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9374352)

  • 1. Decision analysis: MIBI imaging of nonpalpable breast abnormalities.
    Hillner BE
    J Nucl Med; 1997 Nov; 38(11):1772-8. PubMed ID: 9374352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model.
    Hillner BE; Bear HD; Fajardo LL
    Acad Radiol; 1996 Apr; 3(4):351-60. PubMed ID: 8796686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities.
    Waxman AD
    J Nucl Med; 1997 Nov; 38(11):1778-80. PubMed ID: 9374353
    [No Abstract]   [Full Text] [Related]  

  • 4. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results.
    Khalkhali I; Villanueva-Meyer J; Edell SL; Connolly JL; Schnitt SJ; Baum JK; Houlihan MJ; Jenkins RM; Haber SB
    J Nucl Med; 2000 Dec; 41(12):1973-9. PubMed ID: 11138681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintimammography with Tc-99m sestamibi.
    Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
    Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision analysis for the cost effectiveness of sestamibi scintimammography in minimizing unnecessary biopsies.
    Allen MW; Hendi P; Schwimmer J; Bassett L; Gambhir SS
    Q J Nucl Med; 2000 Jun; 44(2):168-85. PubMed ID: 10967626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
    Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
    J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
    Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
    J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
    Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
    J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses.
    Klaus AJ; Klingensmith WC; Parker SH; Stavros AT; Sutherland JD; Aldrete KD
    AJR Am J Roentgenol; 2000 Jun; 174(6):1779-83. PubMed ID: 10845522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide-guided stereotactic prebiopsy localization of nonpalpable breast lesions with normal mammograms.
    Khalkhali I; Mishkin FS; Diggles LE; Klein SR
    J Nucl Med; 1997 Jul; 38(7):1019-22. PubMed ID: 9225782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
    J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
    Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
    Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the cost-effectiveness of Tc-99m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast.
    Chen YS; Wang WH; Chan T; Sun SS; Kao A
    Surg Oncol; 2002 Nov; 11(3):151-5. PubMed ID: 12356511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
    Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases].
    Fliquete Peris MV; Giménez Climent J; Vázquez Forner C; Más Arcas C; Vázquez Albaladejo C
    Rev Esp Med Nucl; 1999 Dec; 18(6):436-41. PubMed ID: 10611570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can scintimammography reduce "unnecessary" biopsies?
    Flanagan DA; Gladding SB; Lovell FR
    Am Surg; 1998 Jul; 64(7):670-2; discussion 673. PubMed ID: 9655280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintimammography in the diagnosis of breast cancer.
    Clifford EJ; Lugo-Zamudio C
    Am J Surg; 1996 Nov; 172(5):483-6. PubMed ID: 8942549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
    Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
    Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.